Emerging Age-Specific Therapeutic Approaches for Dry Eye Disease
Journal of Clinical Medicine · 11.06.2025 · 14 (12) · 4147
DOI: 10.3390/jcm14124147 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.06.2025. Verfasst von Tatiana Suárez-Cortés und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research, Development and Innovation Department (R&D+I Department), FAES Farma, Av. Autonomía 10, 48940 Leioa, Spain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faes Farma S.A..
Abstract (Originalsprache)
Dry eye disease (DED) is a common, multifactorial disorder of the ocular surface. Although DED can affect individuals at any age, its prevalence, clinical manifestations, underlying mechanisms, and optimal management strategies differ considerably across the lifespan. In children, symptoms are frequently associated with atopy and allergic disorders and environmental factors, whereas in young adults, digital device usage and contact lens wear are the predominant contributors. In older adults, systemic diseases and polypharmacy significantly elevate the risk of DED. Across all age groups, tear film instability, decreased tear production, and chronic inflammation are central pathogenic features. Key tear biomarkers, such as pro-inflammatory cytokines, have been widely linked to disease development. Cathepsin S and tumor necrosis factor-alpha have recently been implicated in age-related DED. A nuanced understanding of these age-related differences is crucial for improving diagnostic accuracy and tailoring interventions to specific patient populations. This review synthesizes current evidence on DED across age groups, focusing on prevalence, risk factors, pathophysiology, molecular mechanisms, coexisting conditions, biomarkers, and treatment options. Finally, it highlights critical unmet clinical needs in the management of age-related DED.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research, Development and Innovation Department (R&D+I Department), FAES Farma, Av. Autonomía 10, 48940 Leioa, Spain.
- Neuro-Ophthalmology Department and Pediatric Ophthalmology, Miranza Clínica Begoña, 48006 Bilbao, Spain.
ORCID-Profile: Tatiana Suárez-Cortés
Förderung
- Faes Farma S.A.
Zitieren
APA
Suárez-Cortés, T., & Herrera, I. (2025). Emerging Age-Specific Therapeutic Approaches for Dry Eye Disease. Journal of Clinical Medicine, 14(12), 4147. https://doi.org/10.3390/jcm14124147
Vancouver
Suárez-Cortés T, Herrera I. Emerging Age-Specific Therapeutic Approaches for Dry Eye Disease. Journal of Clinical Medicine. 2025;14(12):4147. doi:10.3390/jcm14124147
BibTeX
@article{SurezCorts2025,
author = {Suárez-Cortés, Tatiana and Herrera, Itxaso},
title = {Emerging Age-Specific Therapeutic Approaches for Dry Eye Disease},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {12},
pages = {4147},
doi = {10.3390/jcm14124147}
}
EUVIMED